Picture of Tokuyama logo

4043 — Tokuyama News Story

0.000.00%
jp flag iconLast trade - 00:00
Basic MaterialsBalancedMid CapSuper Stock

Brief: Tokuyama Corp - Notice Concerning Acquisition Of A Newly Established Company That Will Succeed Jsr's In Vitro Diagnostic Pharmaceutical Business

April 22 (Reuters) - Tokuyama Corp 4043.T:

TOKUYAMA CORP: NOTICE CONCERNING ACQUISITION OF A NEWLY ESTABLISHED COMPANY THAT WILL SUCCEED JSR'S IN VITRO DIAGNOSTIC PHARMACEUTICAL BUSINESS

TOKUYAMA CORP: TO ACQUIRE IN VITRO DIAGNOSTICS AND IN VITRO DIAGNOSTIC PHARMACEUTICAL MATERIALS BUSINESSES HELD BY JSR FOR 82 BILLION YEN

TOKUYAMA CORP: ANY IMPACT OF ACQUISITION OF SHARES ON TOKUYAMA'S CONSOLIDATED FINANCIAL RESULTS FOR FISCAL YEAR ENDING MARCH 31, 2026, IS CURRENTLY BEING ASSESSED

Source text: ID:nTSpv7ea8b

Further company coverage: 4043.T

 (Reporting by Tokyo Newsroom)

 ((+81345201189;))

Recent news on Tokuyama

See all news